FRIDAY, Dec. 13, 2024 (HealthDay News) -- For patients with ductal carcinoma in situ (DCIS), active monitoring (AM) is ...

Centene told investors Tuesday that the company would get additional bonus payments after CMS updated its Medicare Advantage Star Ratings. More health industry news stories report on legal settlements ...

Researchers examined pooled data from two clinical trials that enrolled patients with low- or intermediate-grade ductal ...

A “watch-and-wait” strategy might be the best option for some women with early-stage, low-risk breast cancer.According ...

Every year, about 50,000 women in the US are diagnosed with ductal carcinoma in situ, or DCIS, where the cells that line milk ...

When a woman learns she has breast cancer , her reaction is often: take it out. Now doctors say that might not always be ...

The first study comparing surgery to active monitoring as treatment for ductal carcinoma in situ (DCIS) finds women who carefully monitor the precancerous cells are no more likely to develop breast ...

Some early breast cancer patients can safely avoid specific surgeries, according to two studies exploring ways to lessen ...

ACTIVE monitoring may be a safe and effective treatment option for patients with low-risk ductal carcinoma in situ (DCIS), ...

NEW YORK, Dec. 12 (Xinhua) -- Some women with the earliest stages of breast cancer could be carefully monitored, undergoing surgery and radiation only if the disease advances, new data suggested.

Active monitoring for low-risk ductal carcinoma in situ (DCIS) did not lead to a higher rate of ipsilateral invasive cancer ...